115 related articles for article (PubMed ID: 7190894)
1. Meal-related changes in plasma calcitonin levels in patients with medullary thyroid carcinoma.
Miyauchi A; Morimoto S; Onishi T; Takai S; Okada Y; Himeno S; Kosaki G; Kumahara Y
Endocrinol Jpn; 1980 Apr; 27(2):153-6. PubMed ID: 7190894
[TBL] [Abstract][Full Text] [Related]
2. Gastrin Responses to a test meal in patients with familial medullary thyroid carcinoma.
O'Dorisio TM; Falko JM; Cataland S; Almoney RW; George JM; Mazzaferri EL; Reynolds JC
J Clin Endocrinol Metab; 1982 Apr; 54(4):798-802. PubMed ID: 7061688
[TBL] [Abstract][Full Text] [Related]
3. Relations of calcitonin and gastrin in the Zollinger-Ellison syndrome and medullary carcinoma of the thyroid.
Sizemore GW; Go VL; Kaplan EL; Sanzenbacher LJ; Holtermuller KH; Arnaud CD
N Engl J Med; 1973 Mar; 288(13):641-4. PubMed ID: 4734496
[No Abstract] [Full Text] [Related]
4. Eel calcitonin suppresses plasma human calcitonin levels in medullary carcinoma of the thyroid.
Morimoto S; Miyauchi A; Fukuo K; Imanaka S; Yamamoto H; Tsuchiya H; Koh E; Yukawa S; Onishi T; Avioli LV
Clin Sci (Lond); 1986 Apr; 70(4):333-8. PubMed ID: 3698510
[TBL] [Abstract][Full Text] [Related]
5. Gastro-intestinal polypeptides in patients treated for medullary carcinoma of the thyroid.
Rasmusson B
Acta Endocrinol (Copenh); 1984 May; 106(1):112-5. PubMed ID: 6375228
[TBL] [Abstract][Full Text] [Related]
6. [Radioimmunoassay of the calcitonin gene-related peptide and its measurement in the plasma of patients with medullary thyroid carcinoma and in the cerebrospinal fluid of normal subjects].
Kim S; Morimoto S; Fukuo K; Hironaka T; Koh E; Shiraishi T; Onishi T; Kumahara Y; Kawai Y; Shiotani Y
Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):884-93. PubMed ID: 3500074
[TBL] [Abstract][Full Text] [Related]
7. GH response to growth hormone releasing hormone and hypoglycaemia is unaltered by high endogenous plasma calcitonin levels in patients with medullary thyroid carcinoma.
Popovic V; Micic D; Damjanovic S; Durbaba M; Petakov M; Zoric S; Djurovic M; Manojlovic D; Micic J
Clin Endocrinol (Oxf); 1991 Aug; 35(2):137-9. PubMed ID: 1934528
[TBL] [Abstract][Full Text] [Related]
8. PDN-21: possible tumor marker for medullary thyroid carcinoma.
Takami H; Shikata J; Horie H; Sekine K; Ito K
J Surg Oncol; 1990 Aug; 44(4):205-7. PubMed ID: 2385096
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of thyrocalcitonin secretion by ethanol in patients with medullary thyroid carcinoma--an effect apparently not mediated by gastrin.
Wells SA; Cooper CW; Ontjes DA
Metabolism; 1975 Nov; 24(11):1215-9. PubMed ID: 1186495
[TBL] [Abstract][Full Text] [Related]
10. Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of the thyroid.
Calmettes C; Moudktar MS; Milhaud G
Biomedicine; 1977 Mar; 27(2):52-4. PubMed ID: 861349
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin release from medullary thyroid carcinoma by thyrotropin-releasing hormone: comparison with calcium injection.
Oishi S; Yamauchi J; Fujimoto Y; Hamasaki S; Umeda T; Sato T
Acta Endocrinol (Copenh); 1992 Apr; 126(4):325-8. PubMed ID: 1595326
[TBL] [Abstract][Full Text] [Related]
12. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
[TBL] [Abstract][Full Text] [Related]
13. Plasma calcitonin in medullary thyroid carcinoma.
Lancet; 1983 Feb; 1(8320):338-9. PubMed ID: 6130340
[No Abstract] [Full Text] [Related]
14. Calcitonin in plasma and cerebrospinal fluid from normal subjects and patients with medullary thyroid carcinoma: possible restriction of calcitonin by the blood-brain barrier.
Morimoto S; Nishimura J; Miyauchi A; Takai S; Okada Y; Onishi T; Fukuo K; Lee S; Kumahara Y
J Clin Endocrinol Metab; 1982 Sep; 55(3):594-6. PubMed ID: 7096542
[TBL] [Abstract][Full Text] [Related]
15. Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker.
Marrinan M; Skrabanek P; Moriarty M; McPartlin J; Powell D
Horm Metab Res; 1982 Apr; 14(4):213-5. PubMed ID: 6282727
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of calcitonin gene-related peptide in patients with medullary thyroid carcinoma.
Kim S; Morimoto S; Kawai Y; Koh E; Onishi T; Ogihara T
J Clin Chem Clin Biochem; 1989 Jul; 27(7):423-7. PubMed ID: 2794874
[TBL] [Abstract][Full Text] [Related]
17. The role of serum gastrin in the secretion of calcitonin: studies in patients with pernicious anaemia and in healthy subjects.
Brandsborg M; Nielsen HE; Brandsborg O; Olsen KJ; Løvgreen NA
Scand J Gastroenterol; 1980; 15(1):23-8. PubMed ID: 7367817
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
19. [Endocrinological and clinicopathological studies on medullary thyroid carcinoma. Part 1: Preoperative diagnosis of medullary thyroid carcinoma--physical and roentgenologic findings and determination of plasma calcitonin level (author's transl)].
Obara T
Nihon Gan Chiryo Gakkai Shi; 1976 Dec; 11(4):745-57. PubMed ID: 1035237
[No Abstract] [Full Text] [Related]
20. Concomitant production of immunoreactive gastrin-releasing peptide and calcitonin in medullary carcinoma of the thyroid.
Yamaguchi K; Abe K; Adachi I; Suzuki M; Kimura S; Kameya T; Yanaihara N
Metabolism; 1984 Aug; 33(8):724-7. PubMed ID: 6748945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
